5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.83▼ | 0.83▼ | 0.83▼ | 0.85▼ | 0.98▼ |
MA10 | 0.84▼ | 0.85▼ | 0.85▼ | 0.87▼ | 0.93▼ |
MA20 | 0.85▼ | 0.82▲ | 0.83▲ | 0.98▼ | 0.75▲ |
MA50 | 0.89▼ | 0.97▼ | 0.99▼ | 0.92▼ | 1.00▼ |
MA100 | 0.99▼ | 1.00▼ | 0.99▼ | 0.73▲ | 1.88▼ |
MA200 | 0.96▼ | 0.89▼ | 0.85▼ | 0.90▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.008▲ | 0.008▲ | -0.028▼ | 0.046▲ |
RSI | 46.306▼ | 44.599▼ | 43.847▼ | 43.034▼ | 48.222▼ |
STOCH | 47.342 | 36.755 | 39.131 | 32.723 | 59.578 |
WILL %R | -65.668 | -47.798 | -47.798 | -75.000▼ | -55.814 |
CCI | -58.201 | -35.668 | -12.786 | -62.254 | -2.580 |
CDL | $VIRX Doji Candlestick Pattern Detected | Set Alert |
Tuesday, April 23, 2024 01:03 PM
Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product ...
|
Tuesday, April 23, 2024 11:58 AM
The U.S. Food and Drug Administration (FDA) on Tuesday greenlighted Day One Biopharmaceuticals’ (NASDAQ:DAWN) lead candidate tovorafenib for a type of pediatric brain cancer called low-grade glioma.
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/04/24 | 0.83 | 0.83 | 0.83 | 0.83 | 0 |
24/04/24 | 0.87 | 0.90 | 0.83 | 0.8363 | 55,057 |
23/04/24 | 0.91 | 0.91 | 0.76 | 0.8478 | 84,877 |
22/04/24 | 0.85 | 0.90 | 0.84 | 0.88 | 13,625 |
19/04/24 | 0.8817 | 0.91 | 0.8174 | 0.8567 | 52,615 |
18/04/24 | 0.91 | 0.99 | 0.851 | 0.909 | 79,490 |
17/04/24 | 0.7374 | 0.9499 | 0.7374 | 0.9363 | 196,465 |
16/04/24 | 0.773 | 0.8199 | 0.67 | 0.7148 | 256,597 |
15/04/24 | 1.03 | 1.04 | 0.76 | 0.78 | 606,565 |
12/04/24 | 1.30 | 1.31 | 1.084 | 1.15 | 339,011 |
|
|
||||
|
|
||||
|
|